Certificate says corporate governance provisions do not apply for quarter ended 30 September 2026
Company told BSE that corporate governance rules do not apply to it for the quarter ended 30 September 2026.
By ScoutQuest · · 1 min read
- Quarter
- quarter ended 30 September 2026
- Exemption Basis
- specified securities listed on the SME Exchange, exempt under SEBI LODR Regulation 15
- Corporate Governance Report
- No corporate governance report required for the quarter
Certificate of non-applicability
Chandra Bhagat Pharma has informed BSE that the corporate governance provisions under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 do not apply to it for the quarter ended 30 September 2026.
Why the exemption applies
- The letter cites Regulation 15, which exempts, among others, a listed entity that has listed its specified securities on the SME Exchange.
- The same regulation also covers a listed entity whose paid-up equity share capital does not exceed rupees ten crore and whose net worth does not exceed rupees twenty-five crore, as on the last day of the previous financial year.
- Where the exemption applies, the compliance requirements named in the letter do not apply: Regulations 17, 17A, 18, 19, 20, 21, 22, 23, 24, 24A, 25, 26 and 27, clauses (b) to (i) and (t) of sub-regulation (2) of Regulation 46, and paragraphs C, D and E of Schedule V.
What the company has stated
- Because it falls within the exemption, it is not required to submit a corporate governance report for the quarter ended 30 September 2026.
- The letter is dated 21.10.2026, is addressed to the Manager, Listing Compliance, BSE, and refers to script code 542934.
What this means for a reader
- This is a routine certificate confirming a regulatory exemption that comes with SME listing. It does not comment on the company's business, sales or profits.
- The letter does not contain any financial or operational figures of the company.
- Since no corporate governance report is shared for the quarter, the quarterly governance disclosures that non-exempt listed companies publish do not come through this route for this quarter.
Also from Chandra Bhagat Pharma
Board approves preferential allotment of 66 lakh convertible warrants at Rs. 44/- each
22 Oct 2026
BSE grants in-principle approval for preferential issue of 66,00,000 convertible warrants
13 Oct 2026
Company Secretary & Compliance Officer Rajni Dawani resigns with effect from 30 September 2026
30 Sep 2026
More numbers
- Paid-up equity share capital threshold mentioned for exemptionrupees ten crore
- Net worth threshold mentioned for exemptionrupees twenty-five crore
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.